• Cancer-affected people have a direct impact on their natural appetite and to avoid the risk of suffering from any other disorders due to improper nutrition intake, they need to take a proper nutritious diet. Hence the demand for oncology nutrition in the global market has been rising.
• A number of advancements in the domain of oncology have also led to the growth of the global market and has given rise to several forms of nutrition for cancer patients.
• The Nutritional Oncology Research Institute (NORI) Program is one of the most effective programs designed as an alternative for the treatment of cancers. However, the high cost of cancer treatment such as 120,000 for four doses is hindering the oncology nutrition market.
• One of the recent trends in global Oncology Nutrition market is a shift from parenteral nutrition to enteral nutrition due to its lower cost and complications along with new improvement in materials & compositions.
• The Global Oncology Nutrition market growth is driven by several factors such as the rising incidence of cancer and the growing quality of clinical research on nutritional interventions.
Market Size
• The total number of cancer deaths was estimated to be approx. 9 million globally. Among those, some 1.71 million were deaths due to lung cancer.
• In 2019, an estimated 64,690 people (47,650 men and 17,040 women) will develop head and neck cancer.
Market Segmentation
The Global Oncology Nutrition Market is segmented based on:
• By Cancer Type, into Head and Neck Cancer, Pancreatic Cancer, Stomach and Gastrointestinal Cancer, Liver Cancer, Esophageal Cancer, Breast Cancer, Lung Cancer, Blood Cancer, and Others.
• Among these, the head and neck cancers segment accounted for the largest share of the Oncology Nutrition Market due to the use of tube feeding formulas for patients with head and neck cancers. Head and neck cancer account for about 4% of all cancers in the United States.
Geographical Analysis
• The market is segmented geographically into North America, South America, Europe, Asia-Pacific, and RoW. North America dominates the global Oncology Nutrition market due to the rising prevalence of chronic diseases & disorders, growing elderly population, and increasing healthcare expenditure in this region. United States health spending is projected to rise by 5.3% in 2018, due to rising prices of medical goods and services and higher Medicaid costs.
Competitive Analysis
• The major players in the oncology nutrition market are Abbott Laboratories, Nestle S.A., Danone, Fresenius Kabi AG, and B. Braun Melsungen AG.
• In July 2017, Enterome and Nestle Health Science formed a new company to develop microbiome diagnostics for multiple indications including inflammatory bowel disease (IBD) and liver disorders.
• The report covers the factors impacting the market, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
